NCT05628090View on ClinicalTrials.gov

A Study of an Existing Database to Assess the Treatment Persistence to Basal Insulin in Type 2 Diabetes Mellitus Patients in a Structured Patient Education Program in India

CompletedOBSERVATIONAL
Enrollment

47,885

Participants

Timeline

Start Date

November 30, 2022

Primary Completion Date

December 29, 2023

Study Completion Date

December 29, 2023

Conditions
Type 2 Diabetes Mellitus (T2DM)
Trial Locations (1)

91380

Investigational Site Number :, Chilly-Mazarin

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT05628090 - A Study of an Existing Database to Assess the Treatment Persistence to Basal Insulin in Type 2 Diabetes Mellitus Patients in a Structured Patient Education Program in India | Biotech Hunter | Biotech Hunter